Lung Cancer With Copanlisib and Durvalumab

Clinical trial NCT04895579 · COMPLETED

Trial details

NCT number: NCT04895579
Sponsor: Zhonglin Hao
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2021-05-12
Primary completion: 2025-11-12
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.